Vascularization Pattern After Ischemic Stroke is Different in Control Versus Diabetic Rats: Relevance to Stroke Recovery

Background and Purpose— Pre-existing diabetes mellitus worsens brain functionality in ischemic stroke. We have previously shown that type 2 diabetic rats exhibit enhanced dysfunctional cerebral neovascularization and when these rats are subjected to cerebral ischemic reperfusion injury develop hemorrhagic transformation and greater neurological deficits. However, our knowledge of vascular and functional plasticity during the recovery phase of diabetic stroke is limited. This study tested the hypothesis that vascular repair is impaired in the poststroke period in diabetes mellitus, and this is associated with poor sensorimotor and cognitive function. We further hypothesized that glycemic control prevents impaired vascularization and improves functional outcome in diabetes mellitus. Methods— Vascularization was assessed in the ipsilateral and contralateral hemispheres in control, diabetes mellitus and diabetes mellitus plus metformin groups 14 days after ischemic reperfusion injury, as well as in respective sham controls. Three-dimensional reconstruction of the fluorescein isothiocyanate (FITC)-stained vasculature was achieved by confocal microscopy, and stereological parameters, including vascular volume and surface area, were measured. Astrogliosis was determined by glial fibrillary acidic protein staining. The relative rates of sensorimotor recovery, cognitive decline, and spontaneous activity were assessed. Results— Vascular density in the peri-infarct area was significantly reduced in diabetes mellitus, whereas there was reparative neovascularization in control rats. Astroglial swelling and reactivity were more pronounced in diabetic stroke compared with control stroke. Diabetes mellitus blunted sensorimotor recovery and also exacerbated anxiety-like symptoms and cognitive deficits. Glycemic control started after stroke partially prevented these changes. Conclusions— Diabetes mellitus impairs poststroke reparative neovascularization and impedes the recovery. Glycemic control after stroke can improve neurovascular repair and improve functional outcome.

[1]  T. Dawber,et al.  The Framingham Study , 2014 .

[2]  A. Ergul,et al.  Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes , 2013, PloS one.

[3]  A. Ergul,et al.  Angiogenesis: A Harmonized Target for Recovery After Stroke , 2012, Stroke.

[4]  R. Knight,et al.  Cerebral Myogenic Reactivity and Blood Flow in Type 2 Diabetic Rats: Role of Peroxynitrite in Hypoxia-Mediated Loss of Myogenic Tone , 2012, Journal of Pharmacology and Experimental Therapeutics.

[5]  A. Ergul,et al.  Enhanced Cerebral but Not Peripheral Angiogenesis in the Goto-Kakizaki Model of Type 2 Diabetes Involves VEGF and Peroxynitrite Signaling , 2012, Diabetes.

[6]  Kelly A. Tennant,et al.  Diabetes Impairs Cortical Plasticity and Functional Recovery Following Ischemic Stroke , 2012, The Journal of Neuroscience.

[7]  S. Kiechl,et al.  Functional recovery after ischemic stroke—A matter of age , 2012, Neurology.

[8]  Debraj Mukherjee,et al.  Epidemiology and the global burden of stroke. , 2011, World neurosurgery.

[9]  Christos Davatzikos,et al.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy , 2011, The Lancet Neurology.

[10]  Anthony S. Kim,et al.  Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease , 2011, Circulation.

[11]  P. Wolf,et al.  Inflammatory Markers and Neuropsychological Functioning: The Framingham Heart Study , 2011, Neuroepidemiology.

[12]  E. Syková,et al.  Astroglial networks scale synaptic activity and plasticity , 2011, Proceedings of the National Academy of Sciences.

[13]  M. Endres,et al.  Changes in Cognitive Function over 3 Years after First-Ever Stroke and Predictors of Cognitive Impairment and Long-Term Cognitive Stability: The Erlangen Stroke Project , 2011, Dementia and Geriatric Cognitive Disorders.

[14]  M. Hiltunen,et al.  Chronic Hyperperfusion and Angiogenesis Follow Subacute Hypoperfusion in the Thalamus of Rats with Focal Cerebral Ischemia , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  A. Ergul,et al.  Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  J. Krupiński,et al.  Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke , 2010, Current cardiology reviews.

[17]  Meijia Zhu,et al.  The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  M. Chopp,et al.  Angiogenesis, neurogenesis and brain recovery of function following injury. , 2010, Current opinion in investigational drugs.

[19]  A. Ergul,et al.  Adaptive Cerebral Neovascularization in a Model of Type 2 Diabetes , 2009, Diabetes.

[20]  K. Arai,et al.  Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke , 2009, The FEBS journal.

[21]  A. Ergul,et al.  Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. , 2009, Vascular pharmacology.

[22]  L. Rinaldi,et al.  Recovery from stroke in patients with diabetes mellitus. , 2009, Journal of diabetes and its complications.

[23]  H. Elewa,et al.  Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. , 2009, Stroke.

[24]  M. Chopp,et al.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic , 2009, The Lancet Neurology.

[25]  A. Dorrance,et al.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  V. Gudnason,et al.  American Journal of Epidemiology Original Contribution Cognitive Impairment: an Increasingly Important Complication of Type 2 Diabetes the Age, Gene/environment Susceptibility–reykjavik Study , 2022 .

[27]  P. Gæde Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials. , 2008 .

[28]  E. V. van Dijk,et al.  Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.

[29]  A. Hofman,et al.  Total Cerebral Blood Flow in Relation to Cognitive Function: The Rotterdam Scan Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  O. Pedersen,et al.  Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. , 2008, European journal of endocrinology.

[31]  M. Chopp,et al.  Plasticity and remodeling of brain , 2008, Journal of the Neurological Sciences.

[32]  A. Favier,et al.  Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. , 2008, Clinical science.

[33]  Jerry Silver,et al.  The role of extracellular matrix in CNS regeneration , 2007, Current Opinion in Neurobiology.

[34]  J. Broderick,et al.  Intracranial Hemorrhage Associated With Revascularization Therapies , 2007, Stroke.

[35]  M. Chopp,et al.  Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke , 2007, Stroke.

[36]  J. Krupiński,et al.  Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. , 2006, Clinical science.

[37]  N. Wiernsperger,et al.  Metformin delays the manifestation of diabetes and vascular dysfunction in Goto–Kakizaki rats by reduction of mitochondrial oxidative stress , 2006, Diabetes/metabolism research and reviews.

[38]  Ralph B. D’Agostino,et al.  Obesity, diabetes and cognitive deficit: The Framingham Heart Study , 2005, Neurobiology of Aging.

[39]  Ann M. Stowe,et al.  Extensive Cortical Rewiring after Brain Injury , 2005, The Journal of Neuroscience.

[40]  Benjamin J. Kraus,et al.  Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[41]  D. Ziegler,et al.  Stroke in patients with diabetes mellitus , 2004, Diabetes/metabolism research and reviews.

[42]  J. Sowers,et al.  Stroke in Patients With Diabetes , 2004, Journal of clinical hypertension.

[43]  M. Chopp,et al.  Microvascular structure after embolic focal cerebral ischemia in the rat , 2003, Brain Research.

[44]  A. Tuttolomondo,et al.  Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. , 2003, Stroke.

[45]  Shu-Wei Sun,et al.  Dynamic Changes in Cerebral Blood Flow and Angiogenesis After Transient Focal Cerebral Ischemia in Rats: Evaluation With Serial Magnetic Resonance Imaging , 2002, Stroke.

[46]  W. Duckworth Hyperglycemia and cardiovascular disease , 2001, Current atherosclerosis reports.

[47]  R. Nudo,et al.  Role of adaptive plasticity in recovery of function after damage to motor cortex , 2001, Muscle & nerve.

[48]  S. Vannucci,et al.  Experimental Stroke in the Female Diabetic, db/db, Mouse , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[50]  M. Laakso,et al.  Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.

[51]  C. Wolfe,et al.  Variations in case fatality and dependency from stroke in western and central Europe. The European BIOMED Study of Stroke Care Group. , 1999, Stroke.

[52]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[53]  R. D'Agostino,et al.  NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study , 1997, Diabetes Care.

[54]  T. Olsen,et al.  Stroke in Patients With Diabetes The Copenhagen Stroke Study , 1994, Stroke.

[55]  M. Nishimura,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[56]  G. Schernthaner Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR , 2010, Wiener Medizinische Wochenschrift.

[57]  L. Mogoantă,et al.  Study of vascular microdensity in areas of cerebral ischemia on experimental model. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[58]  P. Gaede Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials. , 2008, Polskie Archiwum Medycyny Wewnetrznej.

[59]  J. Krupiński,et al.  Cerebral Ischemic Stroke , 2005 .